The occurrence of treatment-related grade @ adverse events ( four -LSB- @ % -RSB- of @ patients in the continuation group vs three -LSB- @ % -RSB- of @ in the interruption group ) and grade @ adverse events ( one -LSB- @ % -RSB- vs none ) was similar in both groups .